The Effect of Adding Subarachnoid Epinephrine to Hyperbaric Bupivacaine and Morphine for Repeat Cesarean Delivery: A Double-Blind Prospective Randomized Control Trial

Anesth Analg. 2018 Jul;127(1):171-178. doi: 10.1213/ANE.0000000000002542.

Abstract

Background: Spinal anesthesia has become the most common type of anesthetic for cesarean delivery. The major limitation to spinal anesthesia is that the duration of the anesthetic may not be adequate in the event of a prolonged surgery. Some practitioners add epinephrine to hyperbaric bupivacaine to increase the duration, although its effect has not been fully studied. We therefore aimed to evaluate whether adding epinephrine to the spinal medication prolongs the duration of action of the resultant block in women presenting for repeat cesarean delivery.

Methods: Sixty-eight patients were randomized to receive no epinephrine (NE group), epinephrine 100 µg (low-dose [LD] group), or epinephrine 200 µg (high-dose [HD] group) with a standardized spinal mixture (1.5 mL 0.75% hyperbaric bupivacaine with 0.25 mg morphine). Sixty-five patients were included for primary analysis. Our primary outcome was time to intraoperative activation of the epidural catheter or postoperative regression of sensory blockade to T-10 dermatome level as measured by pinprick sensation; motor recovery was a secondary outcome, and graded via a Modified Bromage scale.

Results: Block onset time, vital sign changes, and the incidence of hypotension; nausea, and vomiting were similar among groups. Median difference in time to T-10 regression was greatest in the HD group compared to the NE group (median difference [min] [95% confidence interval]: 40 [15-60]; P = .007), followed by the HD group to the LD group (30 [15-45]; P = .007). Comparisons of LD to NE were not significant, but trended to an increase in T-10 regression time (10 [-15 to 30]; P = .76). Median difference in time to knee extension (Bromage 3) was also greatest in the HD group when compared to both the LD and NE group (median difference [min] [95% confidence interval]: 30 [0-60]; P = .034, 60 [0-93]; P = .007). Median difference time to knee extension (min) between the LD and NE group was also significant (37.5 [15-60]; P = .001]. Pain scores during the procedure were higher in the NE group (median [interquartile range] HD: 0 [0-0], LD: 0 [0-0], NE: 0 [0-3]; P = .02) during uterine closure and were otherwise not significantly different from the other groups.

Conclusions: In this single center, prospective, double-blind, randomized control trial, the addition of epinephrine 200 µg to hyperbaric bupivacaine and preservative-free morphine for repeat cesarean delivery prolonged the duration of the sensory blockade. Motor blockade was similarly prolonged and block quality may have been enhanced.

Trial registration: ClinicalTrials.gov NCT02369510.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Analgesia, Obstetrical / adverse effects
  • Analgesia, Obstetrical / methods*
  • Analgesics, Opioid / administration & dosage*
  • Analgesics, Opioid / adverse effects
  • Anesthesia, Obstetrical / adverse effects
  • Anesthesia, Obstetrical / methods*
  • Anesthesia, Spinal / adverse effects
  • Anesthesia, Spinal / methods*
  • Anesthetics, Local / administration & dosage*
  • Anesthetics, Local / adverse effects
  • Bupivacaine / administration & dosage*
  • Bupivacaine / adverse effects
  • Cesarean Section, Repeat / adverse effects*
  • Double-Blind Method
  • Epinephrine / administration & dosage*
  • Epinephrine / adverse effects
  • Female
  • Humans
  • Labor Pain / diagnosis
  • Labor Pain / drug therapy*
  • Labor Pain / etiology
  • Morphine / administration & dosage*
  • Morphine / adverse effects
  • Motor Activity / drug effects
  • Nerve Block / adverse effects
  • Nerve Block / methods*
  • New York City
  • Pain Measurement
  • Pain Threshold / drug effects
  • Pain, Postoperative / diagnosis
  • Pain, Postoperative / etiology
  • Pain, Postoperative / prevention & control
  • Pregnancy
  • Prospective Studies
  • Recovery of Function
  • Subarachnoid Space
  • Time Factors
  • Treatment Outcome

Substances

  • Analgesics, Opioid
  • Anesthetics, Local
  • Morphine
  • Bupivacaine
  • Epinephrine

Associated data

  • ClinicalTrials.gov/NCT02369510